Home

RFA-CA-23-003 - Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 4

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology NOT-CA-23-060 NCI Apr 17, 2023 Jan 8, 2026 R33, R21, U01, R61, R03
Notice of Special Interest (NOSI): Technology Development for Cancer Control and Population Science Research NOT-CA-23-037 NCI Jan 18, 2023 Dec 31, 2024 U01, R21, R61, R33, U24
Notice of Special Interest (NOSI): Technologies and Informatics Tools for Cancer Metabolomics NOT-CA-22-083 NCI Apr 26, 2022 Dec 31, 2024 R33, R61, R21, U24, U01

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology NOT-CA-22-003 NCI Nov 30, 2021 May 8, 2023 R03, R61, R33, R21


Technical Issues: E-mail OER Webmaster   




  • National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, Maryland 20892

  • NIH... Turning Discovery Into Health